Richter-Helm BioLogics is a prominent biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of microbial-derived biopharmaceuticals. The company operates two cGMP-compliant manufacturing facilities in Germany, which are equipped to handle a range of products derived from bacteria and yeasts. Their expertise encompasses the production of recombinant proteins, peptides, antibody-like scaffolds, plasmid DNA, and bacterial vaccines. With over 35 years of experience, Richter-Helm has established a strong track record in microbial production, catering to a diverse clientele that includes large pharmaceutical companies as well as small and mid-sized biotech firms.

The company emphasizes a flexible and transparent approach to project management, offering customized analytics and reliable production capabilities. Their facilities are approved by major regulatory bodies, including the EMA and FDA, and are capable of handling fermenter volumes ranging from 10L to 1500L. Richter-Helm is committed to expanding its process development and quality control capacities, ensuring that they meet the evolving needs of their clients while adhering to stringent quality standards. This focus on innovation and quality positions Richter-Helm as a key player in the biopharmaceutical manufacturing landscape.

Germany

Richter-Helm BioLogics

Europe - West

Antibodies

Richter-Helm BioLogics

Company Details